Background & relevance

With BCG therapy, immunotherapy is used in bladder cancer for ages. Recently, the new immune checkpoint inhibitors have been a game changer for advanced disease. However, these drugs are not a one size fits all solution.

Regulatory approval status of immunotherapy for metastatic UCa (status: 15 December 2022)

Back